Apr 29, 2019 - Cigna's (CI) Q1 earnings should benefit from increase in revenues and membership.
Apr 29, 2019 - They could be big winners for patient investors.
Apr 29, 2019 - Pfizer (PFE) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Apr 28, 2019 - For Sangamo's (SGMO) Q1, investor focus will be on its gene therapy candidate, SB-525, currently under evaluation for hemophilia A. The company also boasts several other early-stage promising candidates in its pipeline.
Apr 25, 2019 - SS&C Technologies (SSNC) efforts to strengthen its cloud-based and AI technologies are likely to drive the top line.
Apr 24, 2019 - While Pfizer's (PFE) key drugs like Ibrance and Xeljanz are likely to drive Q1 sales, genericization of key drugs and weak sales in the EH segment will hurt.
Apr 23, 2019 - Drugmakers battle for patients.
Apr 23, 2019 - Pfizer (PFE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Apr 22, 2019 - Bayer (BAYRY) is expected to provide pipeline updates along with its first-quarter results.
Apr 22, 2019 - During Exact Sciences' (EXAS) first-quarter 2019 conference call, investor focus will be on the growth rate in the company's non-invasive screening test volume for colorectal cancer, Cologuard.